Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Diluted EPS Excl. Extra Items

Rigel Pharmaceuticals Diluted EPS Excl. Extra Items Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Diluted EPS Excl. Extra Items from 2010 to 2020. Earnings per share (EPS) is the portion of a company's profit allocated to each outstanding share of common stock. Earnings per share serves as an indicator of a company's profitability. EPS is calculated as: EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.
  • Rigel Pharmaceuticals Diluted EPS Excl. Extra Items for the quarter ending September 09, 2020 was $0m a -22.30% increase of 0m year over year
  • Rigel Pharmaceuticals Diluted EPS Excl. Extra Items for the last 12 months ending September 09, 2020 was $0m a -142.88% increase of 0m year over year
  • Rigel Pharmaceuticals Annual Diluted EPS Excl. Extra Items for 2019 was $0m a -9.87% increase of 0m from 2018
  • Rigel Pharmaceuticals Annual Diluted EPS Excl. Extra Items for 2018 was $0m a -40.62% increase of 0m from 2017
  • Rigel Pharmaceuticals Annual Diluted EPS Excl. Extra Items for 2017 was $-1m a -18.78% increase of 0m from 2016
Other Per Share Metrics:
  • Rigel Pharmaceuticals Diluted EPS Incl. Extra Items for the quarter ending December 12, 2018 was $0m a 998.79% increase of 0m year over year
View Chart On Koyfin

Quarterly RIGL Diluted EPS Excl. Extra Items Data

09/2020$0m
06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$0m
12/2018$0m
09/2018$0m
06/2018$0m

Annual RIGL Diluted EPS Excl. Extra Items Data

2019$0m
2018$0m
2017$-1m
2016$-1m
2015$-1m
2014$-1m
2013$-1m
2012$-1m
2011$-1m
2010$1m